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Abstract
Background: Orthodontic tooth movement (OTM) is an interaction between the 
mechanical forces applied on the tooth and the response of biological tissues of the 
oral cavity to those forces. Bone has the ability of self-repair as well as it can adapt to 
changes in the mechanical needs of the body. The triggering factor for OTM is a strain 
on the periodontal ligament (PDL). Mechanical forces applied in orthodontic treatment 
cause the physical distortion of PDL and alveolar bone cells resulting in activation of 
inflammatory pathways, such as the prostaglandin pathway. Osteoclast formation has 
seen to be increased after the activation of T-cells, whereas the food derivatives such as 
sulforaphane and natural isothiocyanate are observed to promote osteoblastic activity. 
However, these agents get flushed by blood circulation rapidly. Although, there is a 
possibility that the agents that enhance bone formation and bone resorption can accelerate 
tooth movement and shorten the time of orthodontic therapy. Aim: The objective of the 
review is to highlight the inflammatory process involved in the orthodontic treatment as 
well as bone remodeling, ultimately to understand how modulation of the inflammatory 
process of the immune system with the help of external agents can enhance the OTM. 
Conclusion: The advantages of inflammatory mediators can be utilized in orthodontic 
therapy that can give a novel perspective to orthodontic treatment. However, this demands 
a thorough understanding of the biology of oral tissues at cellular as well as molecular 
level as our knowledge is limited in this perspective. Therefore, more studies and research 
work should be motivated in the field of oral biology to bring better treatment outcomes 
in less amount of time. Clinical Significance: The understanding of concepts related to 
inflammatory processes as well as bone remodeling will help us to develop modulators in 
future that will resolve the problem of extended treatment time involved in orthodontic 
treatment. Hence, the knowledge of cellular biology can be applied to make orthodontic 
more efficient by reducing the treatment time as well as events of relapse.
Keywords: Bone remodeling, immune response, inflammatory mediators, modulators, orthodontic 
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Introduction
Orthodontic tooth movement (OTM) is the movement of a 
tooth under the influence of mechanical forces. The orthodontic 
forces are the intentional forces applied to the teeth to move 
them in a particular direction. OTM demands the presence of 
a functional and healthy periodontal ligament (PDL).[1,2] OTM 
differs appreciably from physiological tooth movement and 
movement of teeth at the time of the eruption. Physiological 
tooth movement is characterized by the displacement of teeth in 
the buccal direction into the cancellous bone as seen as a result 
of growth into cortical bone.[3] The orthodontic movement is 
uniquely characterized by the sudden creation of compression 
and tension regions in the PDL.[4]
The triggering factor for OTM is a strain on the PDL, 
eventually on the bone-related cells as well as the extracellular 
matrix. This strain subsequently leads to multiple changes in 
gene expression in these cells as a result of interactions between 
cells and the extracellular matrix. Consequently, it leads to 
the activation of a variety of cell-signaling pathways, which 
ultimately leads to stimulation of PDL to initiate the process of 
bone resorption and deposition.
New methods to accelerate OTM are being developed to 
reduce the orthodontic treatment time as well as to reduce 
side effects resulting from orthodontic action such as pain, root 
resorption associated that at times lead to the development 
of non-vital teeth.[5] One of the methods that are being used 
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to reduce treatment time is by use of low friction and self-
ligating brackets,[6,7] preformed robotic archwires,[8,9] and use of 
microimplants.[10,11]
Other methods focus on increasing the velocity of OTM 
by enhancing the bone remodeling. These methods include 
use of biochemical agents, mechanical, or physical stimulation 
of the alveolar bone that involves the use of cyclic vibration,[12] 
magnets,[13] or direct electrical current,[13] and surgical 
interventions to accelerate tooth movement.[14] Therefore, the 
researchers are inclined to developing the least invasive methods 
that enhance the OTM as well as cause minimal side effects to 
the patients.[15]
The processes involved in OTM can be modulated by 
systemic as well as local application of medications by a 
stimulatory or inhibitory effect. The commonly used are dietary 
supplements, such as vitamins and minerals.[15-18]
Bone
Bone is a dense connective tissue, and the bone matrix is 
mineralized fibrous tissue. The minerals embedded in the 
matrix of bone provide the compressive strength, and the fibers 
provide adequate tensile strength.[19] Bone has the ability of 
self-repair as well as it can adapt to changes in the mechanical 
needs of the body.[20] Osteoclasts are large multinuclear cells, 
about 50–100 µm in diameter and have the function to break 
down bone tissue with the help of enzymes. Osteoclasts are the 
exocrine cell that dissolves bone minerals and enzymatically 
degrade extracellular matrix of bone. They are derived from 
hematopoietic stem cells of the body. The mononuclear 
osteoclasts adhere tightly to a bone and fuse with each other into 
multinucleated osteoclasts.[21] The remodeling process helps the 
bone to adapt to changes in long-term loading.[22]
Bone remodeling
Bone remodeling is a continuous process of the body under 
normal conditions. Bone remodeling helps the bone to maintain 
its volume as well as its strength to meet the physiological 
demands of the bone.[23] The “pressure-tension theory” that is 
associated with OTM states that the application of physiologic 
force, whether compression or tension resulting in changes 
in the PDL space activates mesenchymal stem cells. As a 
result, the progenitor cells in the PDL that experience force 
will differentiate into compression associated osteoclasts 
and tension-associated osteoblasts, causing bone resorption 
and apposition, respectively.[24] Mechanical forces may cause 
hyalinization that leads to necrosis in the PDL, resulting in bone 
resorption. Hyalinization can be defined as cell-free areas in the 
PDL wherein the standard tissue architecture, as well as the 
staining characteristics of collagen in the processed histologic 
material, are lost.[25]
Types of tooth movement
Common types of tooth movements are tipping, bodily 
movement, rotation, and intrusion/extrusion movement. 
Tipping is considered the most natural type of tooth movement. 
It results when a single force is applied and the tooth tips around 
its center of rotation that is located in the middle of the root, 
close to its center of resistance.[19] OTM can be defined as a 
response to disturbance in the physiological equilibrium of 
the dentofacial complex by external forces.[17] To explain the 
biological response, two theories have been developed, pressure-
tension theory, and bone bending theory.[11]
Immune response to orthodontic tooth movement
OTM results due to the bone remodeling sequence that is 
induced by therapeutic mechanical stress. The mechanical strain 
on the tooth is transferred to the PDL and therefore, cells in the 
PDL respond to the mechanical stress to regulate the resorption 
and formation of the bone matrix by signaling the surrounding 
cells.[26] The Osteoclasts on the compressed side of PDL of the 
tooth resorb the alveolar bone.[16,27,28]
Bone bending theory is based on the assumption that 
deformation in the alveolar bone is the primary cause of bone 
remodeling, so the pressure state (positive or negative) of the 
bone matrix is the first stimulus to differentiate apposition and 
resorption in overloaded conditions. Whenever the orthodontic 
appliance is activated, forces delivered to the tooth are transmitted 
to all tissues around the force application.[19] Another outcome 
of the physical distortion by forces on the paradental tissues is its 
effect on peripheral nerve fibers and terminals. Neuropeptides 
stored in nerve terminals within the PDL either may be released 
into the extracellular space as the applied stress persists or stream 
toward the ganglion.[29]
Molecular basis of bone remodeling
Many genes are involved in osteoblast differentiation. The 
transcription factor (TF) Cbfa1 (or Runx2) is one of the 
most specific bone formation markers that control osteoblast 
differentiation.[24]
Role of inflammation in tooth movement
Inflammation is described as a protective response to insult 
with pathogens, injury, or foreign bodies encountered by 
host tissues. The process of inflammation is characterized by 
vascular dilation, enhanced permeability of capillaries, increased 
blood flow, and leukocyte recruitment. Polymorphonuclear 
neutrophils are the first cells to reach the inflamed site.[30] The 
bioactive lipid mediators, primarily eicosanoids, are involved 
in pathophysiologic processes, including those associated 
with host defense and inflammation.[17,31,32] Prostaglandins 
are chemical messengers that belong to a family of hormones 
called eicosanoids. The major types of eicosanoids are 
prostaglandins, thromboxanes, and leukotrienes. Prostaglandins 
are produced from arachidonic acid in the body, and arachidonic 
acid is derived by enzyme phospholipase A2 that acts on 
phospholipids containing arachidonic acid.[33] Prostaglandins 
have ten subtypes, of which D, E, F, G, H, and I are the most 
important.[31,34] Prostaglandin E2 is generated through 
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prostaglandin E synthase in leukocytes, whereas prostaglandin 
I2 is generated through prostacyclin synthase in endothelial cells 
and thromboxanes are made through thromboxane synthase in 
platelets.[35] Leukotrienes are produced by inflammatory cells 
such as macrophages and mast cells.[17]
The production of immuno resolvents initiates resolution 
of inflammation. The lipid mediators that are synthesized 
during the resolution phase of inflammation including resolvins, 
protectins, lipoxins, and maresins.[36] Lipoxins are produced 
from endogenous fatty acids, mainly the arachidonic acid. They 
have potent anti-inflammatory and resolution actions.[27,37,38] 
Lipoxins A4 and B4 are mainly known for their actions like 
inhibition of polymorphonuclear neutrophil infiltration and 
as stimulation of recruitment of macrophages.[39,40] Other 
immuno resolvents such as resolvins, protectins, and maresins 
are derived from dietary fatty acids, essentially ω-3 fatty acids 
which are commonly derived from fish. Production of resolvin 
E1 is shown to be associated with the concentration of aspirin 
in plasma, hence results in amelioration of the clinical signs 
of inflammation.[41,42] Similarly, D-series resolvins that are 
docosahexaenoic acid-derived resolvins reduce inflammation by 
reducing platelet-leukocyte adhesion.[43] Thus, it is evident that 
resolution of inflammation is carried out by protective mediators 
that are arachidonic acid-derived lipoxins, aspirin-triggered 
lipoxins, ω3-eicosapentaenoic acid derived resolvins of the 
E-series, docosahexaenoic acid-derived resolvins of the D series, 
protectins, and maresins.[44]
Mechanical forces applied in orthodontic treatment cause 
the physical distortion of PDL and alveolar bone cells resulting 
in activation of pathways, such as the prostaglandin E2 (PGE2) 
pathway, that in turn results in structural and functional 
changes in the extracellular, cell membrane, and cytoskeletal 
proteins.[25]
Cytokines as mediators of mechanically induced bone 
remodeling Cytokines 8 are mediators released from cells, which 
modulate the activity, of other cells. The first ones identified were 
lymphokines produced by lymphocytes, and the term cytokines 
are used. Inflammatory cells produce numerous cytokines, which 
mediate various stages of inflammation. Some of these cytokines 
mainly interleukin–1 alpha, and one beta, tumor necrosis factor, 
gamma interferon have been implicated in the mediation of the 
bone remodeling process in vitro.[29]
The earliest bone resorption marker is the interleukin1 
beta (IL-1β). PGE2, and interleukin-6 (IL-6) are also other 
inflammatory cytokines that can facilitate osteoclastic bone 
resorption processes.[24,45] Osteoblastic cells also control 
osteoclastic processes by synthesizing RANKL to promote more 
osteoclastic differentiation.[24,46] Moreover, bone formation 
induced by orthodontic forces resulted in increased levels of 
ALP were human gingival crevicular fluid supporting the idea 
that they might have biological activities in the early stages of 
tooth movement.[18,47]
Nitric oxide (NO) is also a crucial regulator of bone 
responses to mechanical stress and is produced by the activity 
of enzyme nitric oxide synthase (eNOS) or inducible nitric 
oxide synthase (iNOS) present in the endothelium. It enhances 
bone formation as well as protects osteocytes from apoptosis. It 
also helps in osteoclastic activity.[48] Recent reports proposed a 
role for nitric oxide as a marker of vascular signal transduction 
during the initial state of orthodontic tooth movement.[49-51] This 
molecule has shown to be a participant in bone remodeling and 
the regulation of blood vessels and nerves.[52,53]
Modulators of orthodontic tooth movement
Various new methods are being tried to accelerate OTM to 
shorten treatment times as well as to reduce side effects such as 
pain, discomfort, and side effects of root resorption resulting in 
subsequent development of non-vital teeth.[5] Numerous reports 
have described the pharmacological acceleration of OTM 
through the activation of osteoclasts. However, because these 
drugs are rapidly flushed by blood circulation, daily systemic 
administration, or daily local injection is needed.[54]
Vitamin D
Bioactive 25(OH) D3 and 1,25 (OH)2D3, as well as 24R,25 
(OH)2D3 can stimulate osteoblast growth and differentiation 
in vitro.[55] 1,25(OH)2 D3 when administered in vivo for 28 
consecutive days, increased bone formation and reduced bone 
resorption and increased trabecular bone volume in mice.[56] It 
was observed that long-term administration of 1α,25[OH](2)-
2β- (3hydroxypropyloxy)vitamin D3 metabolite (eldecalcitol) 
reduced the bone turnover.[57]
It is a steroid hormone having specific receptors in many 
organs and tissues. It acts by activating DNA and RNA in the 
cells of the target organ to produce proteins and enzymes that 
work in the bone resorption process. In particular, the active 
form of Vitamin D, 1,25-dihydroxycholecalciferol, is one of 
the most potent stimulators of osteoclastic activity known.[33] 
Collins and Sinclair,[58] as well as Kale et al.,[59] have reported that 
the local administration of Vitamin D increased the rate of tooth 
movement in cats and rats, respectively.
Bisphosphonates
Bisphosphonates antagonize osteoclastogenesis through 
various mechanisms of action.[60] Long-term oral or parenteral 
administration of bisphosphonates increases bone mineral 
density as well as bone volume, whereas it reduces bone porosity 
and risk of fracture. However, bisphosphonate therapy has 
side effects. Most common among these is gastrointestinal 
intolerance. Moreover, both oral and parenteral administration 
of bisphosphonates can lead to osteonecrosis of the jaw.[61,62]
The topical administration of a potent blocker of bone 
resorption, bisphosphonate (risedronate), caused a significant 
and dose-dependent reduction of tooth movement and inhibited 
relapse of tooth movement in rats.[63] Bisphosphonates selectively 
inhibit osteoclasts and have been used to treat various metabolic 
bone diseases associated with excessive bone resorption.[64]
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Clodronate is a non-N-containing bisphosphonate that 
contains two chlorine atoms in its side-chain. As a result of its 
structural similarity to pyrophosphate, it is known to inhibit 
osteoclast function.[65]
The local administration of clodronate did not cause any 
visible inflammatory reactions at the injection site or any 
systemic side effects, such as loss of appetite or change in 
body weight. The local administration of clodronate caused 
a significant reduction in tooth movement in the third phase, 
which is considered to be due to bone resorption by osteoclasts. 
This indicates that clodronate inhibits bone resorption induced 
by orthodontic mechanical stress.[66] Tooth movement on the 
control side exhibited three typical phases, i.e a period of rapid 
change, a lag phase, and a phase of progressive movement.[67]
Prostaglandins
Leiker et al.[68] studied the effect exogenous PGE2 on the rate of 
tooth movement in rats. According to his reports, injections of 
exogenous PGE2 did enhance the amount of tooth movement. 
Kehoe et al.[69] administered misoprostol (100 mg/kg) twice 
daily in guinea pigs and noted a significant increase in the degree 
and rate of orthodontic tooth movement. In a study by Sekhavat 
et al.,[70] it was observed that misoprostol enhances tooth 
movement in doses as low as 10–25 mg/kg, twice daily, without 
increasing the amount of root resorption.
Nonsteroidal Anti-inflammatory Drugs
Cyclooxygenase inhibitors such as indomethacin and other 
nonsteroidal anti-inflammatory drugs (NSAIDs), which inhibit 
prostaglandin synthesis, inhibit the appearance of osteoclasts.
Orthodontic mechanical forces produce inflammation in 
periodontal tissues.[16] According to them, celecoxib suppressed 
tooth movement as well as root resorption. On the contrary, 
aspirin, acetaminophen, and meloxicam do not seem to affect 
orthodontic tooth movement.[71] Chumbley and Tuncay[72] 
showed that indomethacin inhibited orthodontic tooth 
movement. Celecoxib and prednisolone have proved to show an 
inhibitory effect on osteoclastic as well as odontoclastic activities. 
While a low dose of celecoxib decreased tooth movement, it did 
not affect root resorption.[71] Further work by Yamasaki showed 
that local prostaglandin injection could also increase the rate of 
OTM in primates.[73]
Tetracycline may have a similar potential while presenting fewer 
side effects since it can be used in its non-antimicrobial form.[74]
Miscellaneous
Osteoclast formation has seen to be increased after the 
activation of T-cells, whereas the food derivatives such as 
sulforaphane and natural isothiocyanate are observed to 
promote osteoblastic activity through epigenetic mechanisms 
by increasing matrix mineralization. The flavonoids stimulate 
calvarial osteoblast proliferation and mineralization.[75] The 
other bone protecting agents are the growth factors, such as 
BMP, fibroblast growth factor (FGF), and vascular endothelial 
growth factor (VEGF).[76]
Substances with Anti-Cathepsin effect
The newly discovered molecule with an antiosteoporotic effect 
is the monoclonal antibody against cathepsin K (CTSK).[77] 
Cathepsin K is known to be a proteolytic enzyme that degrades 
collagen I in the bone matrix and activates bone resorption. 
The cathepsin K antibody, due to the coupling between bone 
resorption and bone formation, inhibits both these processes, 
but more markedly bone resorption and only transiently 
bone formation. Long-term administration of cathepsin K 
antibodies, such as odanacatib, increased BMD and decreased 
the fracture rate.[78,79] Further non-traditional molecules with 
antiosteoporotic potential.
New molecules with anti-sclerostin effects
Subcutaneous administration of monoclonal anti-sclerostin 
antibodies, such as AbD09097, stimulates bone formation and 
increases bone mass through activation of the Wnt pathway, 
independently of bone remodeling.[80,81]
Other non-invasive techniques
Low-level laser therapy
Low-level laser therapy (LLLT) is better called as 
photobiomodulation, or biostimulation implicates the 
administration of either low levels of red light or near infrared 
wavelength to treat a variety of diseases. There are commonly 
known as cold laser as it does not increase the local tissue 
temperature by more than 1°C42, 43. At the cellular level, LLLT 
acts on mitochondria,[82] which increases adenosine triphosphate 
(ATP) production and the induction of TF.[83,84] The TF stimulate 
protein synthesis and lead to cell proliferation as well as migration. 
They can also change the levels of cytokines, inflammatory 
mediators, and growth factors.[85] As LLLT accelerates bone 
regeneration and remodeling by increasing vascularization, 
promoting trabecular osteoid tissue formation, and enhancing 
tissue metabolism;[86] therefore, it was thought to be beneficial also 
in the acceleration of orthodontic tooth movement.[15]
Low-intensity pulsed ultrasound
Ultrasound is basically a sound wave that can be transmitted 
into biological tissues, and it has a frequency above the limit of 
human ear perception, which. It is used in the field of medicine 
for diagnostic as well as therapeutic purpose.[87] In a recent study 
conducted on a rat model, LIPUS enhanced the OTM by 45%. 
Moreover, it promoted alveolar bone remodeling as well.[88]
Mechanical vibration
Low-level mechanical vibration has a considerable effect on 
musculoskeletal morphology.[89] Automated vibration signals 
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can promote bone healing, enhance bone strength, and reduce 
the adverse impact of the catabolic process.[90] It is speculated 
that mechanical vibration can reduce the period in the lag phase 
during OTM resulting in painless and rapid change.[91]
Conclusion
The discussion in the earlier sections makes it clear that if 
the advantages of inflammatory mediators are applied to 
orthodontic therapy, keeping the side effects minimal, then it 
can bring a new perspective to orthodontic treatment. However, 
this requires the extensive knowledge of body system at the 
cellular and molecular levels. Moreover, a better understanding 
of molecular biology and its consequences on cellular physiology 
will help to modulate growth processes and immune responses. 
Therefore, it demands robust research in the field of oral biology. 
To summarize, research in the field of cellular and molecular 
biology is lagging, and enhancement in the field of oral sciences 
will help to develop innovative orthodontic therapies that will 
correct malocclusions efficiently and with minimal side effects.
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